BindingDB logo
myBDB logout

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
14613327 46 5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.EBI Abbott Laboratories
12166937 26 Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors.EBI Abbott Laboratories
11549437 17 Synthesis and biological evaluation of clitocine analogues as adenosine kinase inhibitors.EBI Abbott Laboratories
11405650 42 Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor..EBI Abbott Laboratories
11140740 65 Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.EBI Abbott Laboratories
12721338 61 N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.BDB Pudue Pharma Discovery Research
1352553 38 Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.BDB University of North Carolina
17154503 8 Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.BDB Abbott Laboratories